Clinical Trials at Blue Ridge Cancer Care
As of August 2026, 12 paid clinical trials are recruiting at Blue Ridge Cancer Care, located at 2522 COLONIAL AVE SW, ROANOKE, VA 24015-3121, phone (540) 343-0055 in Roanoke, Virginia. Active studies at this site cover conditions such as Ulcerative Colitis, Breast Neoplasms and Cardiovascular Diseases. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
12 clinical trials at Blue Ridge Cancer Care
·Clear filters·A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Common conditions studied in Roanoke
- Ulcerative Colitis (5 active studies)
- Breast Neoplasms (4 active studies)
- Cardiovascular Diseases (4 active studies)
- Heart Failure (4 active studies)
- Prostate Cancer (4 active studies)
- B Acute Lymphoblastic Leukemia (3 active studies)
Leading research sponsors in Roanoke
- Virginia Polytechnic Institute and State University
- Merck Sharp & Dohme LLC
- Children's Oncology Group
- National Cancer Institute (NCI)
- Pfizer
Frequently asked questions
How many paid clinical trials are currently recruiting in Roanoke?
There are approximately 156 recruiting clinical trials in Roanoke, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Roanoke pay participants?
Most recruiting trials in Roanoke compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Roanoke?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Roanoke?
The most common conditions under active study in Roanoke include Ulcerative Colitis (5), Breast Neoplasms (4), Cardiovascular Diseases (4), Heart Failure (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Roanoke?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Roanoke on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Roanoke?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Roanoke?
Recruiting research sites in Roanoke include Carilion Clinic, Carilion Children's, Carilion Roanoke Memorial Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Roanoke right now?
The largest active categories in Roanoke are Cancer & tumors (58), Neurology & pain (10), Cardiovascular (9). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Blue Ridge Cancer Care?
Blue Ridge Cancer Care is located at 2522 COLONIAL AVE SW, ROANOKE, VA 24015-3121. Use the Google Maps link in the intro above to get directions.
How do I contact Blue Ridge Cancer Care?
You can reach Blue Ridge Cancer Care by phone at (540) 343-0055. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.